文献速递头颈外科

改良下颌下腺转移术联合调强放疗减少头颈癌口干症

Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
PubMed 文献 · Head Neck · 2020-05-13

术后无手术并发症,随访24.5个月,中重度口干症发生率为16.7%,无局部区域复发,仅1例远处孤立肺转移。结论认为该改良技术实用有效,可减少对侧下颌下腺放疗剂量并限制治疗后口干症。

要点

  • 改良下颌下腺转移术保留同侧颌面动静脉,简化了手术操作。
  • 随访24.5个月,中重度口干症发生率为16.7%,无局部区域复发。

核心结论

  • 改良下颌下腺转移术是减少对侧下颌下腺放疗剂量并限制治疗后口干症的实用有效方法。

主要发现

  • 改良下颌下腺转移术未导致 minor 或 major 并发症。
  • 随访24.5个月时,治疗后中重度口干症发生率为16.7%。
  • 无局部区域复发,仅1例患者出现远处孤立肺转移。

临床怎么用

  • 对于计划接受双颈调强放疗的头颈癌患者,可考虑采用保留同侧颌面动静脉的改良下颌下腺转移术以降低口干症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Xerostomia is one of the most common long-term adverse effects of radiotherapy for head and neck cancer patients. Contralateral submandibular gland transfer (SMG-T) before radiotherapy was shown to reduce xerostomia compared to pilocarpine. We sought to evaluate a modification of this surgery preserving the ipsilateral facial artery and vein to simplify the SMG-T. METHODS: Eighteen patients planned for head and neck intensity modulated radiotherapy to both necks were reviewed. Surgical complications were recorded. The grade of xerostomia was assessed after treatment completion. RESULTS: There were no minor or major complications resulting from the modified SMG-T. At 24.5-months follow up, the incidence of post-treatment moderate to severe xerostomia was 16.7%. No locoregional recurrence occurred. Only one patient had distant solitary lung metastasis. CONCLUSION: The modified SMG-T technique is a practical and effective method to reduce the dose of radiation to the contralateral SMG and limit post-treatment xerostomia.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Chang CF, Ei-Sayed IH, George JR, et al. Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients. Head Neck. 2020. PMID: 32400948. doi:10.1002/hed.26249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。